https://www.selleckchem.com/products/azd3514.html
Food and Drug Administration (FDA) rules restrict pharmaceutical manufacturers from promoting drugs for non-FDA-approved (off-label) indications. When manufacturers violate this rule, it has in many cases led to unsafe prescribing. However, in 2012, a federal circuit court ruled in United States v. Caronia that truthful off-label promotion was protected under the First Amendment, threatening government enforcement in this area. The authors extracted cases from the WestLawNext database that mentioned Caronia from 2012 to 2019. They colle
Like
Comment
Share
